PRL and cardiovascular disorder: Based on these findings, in women with prolactinomas after menopause, besides the common higher risk of developing cardiovascular diseases as compared to fertile age, a further increase in cardiovascular risk might depend on the metabolic impact of PRL excess, thus suggesting a greater risk of a cardiovascular event in these patients as compared to healthy postmenopausal women.